Revenue for the quarter was $3.76 million with operating income of $36.23 million.
The Watertown, Massachusetts (MA)-based company operating in the biological products, except diagnostic substances sector has total shareholders equity of $262.47 million.
Also read:
This is a developing story. Click
here to receive updates.
------------
NewsInMinutes, an offering of 10kInfo, Inc., brings you news on the latest regulatory filings. Subscribe to additional news alerts
here.